ArticleBMC psychiatry2021
Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients.
Article in BMC psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 23 citations in OpenAlex.
- Validation of the Arabic version of the "Cognitive Theory of Mind (ToM-15) scale" among Lebanese patients with schizophrenia.Schizophrenia research. Cognition · 2026Article
- Does neurocognition predict personal recovery over time in psychotic disorder patients?Schizophrenia research. Cognition · 2026Article
- Arabic validation and adaptation of the Screen for Cognitive Impairment in Psychiatry (SCIP-A) in university students: a pilot study.Frontiers in psychology · 2026Article
- Exploring theory of mind abilities in Lebanese chronic patients with schizophrenia: A cross-sectional study.Schizophrenia research. Cognition · 2025Article
- Validation of the Arabic version of the 16-item free and cued recall test among patients with schizophrenia.BMC psychiatry · 2025Article
- Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities.Schizophrenia bulletin · 2025Review
- Development and Evaluation of a Cognitive Battery for People With Schizophrenia in Ethiopia.Schizophrenia bulletin · 2024Article
- Self-report versus performance based executive functioning in people with psychotic disorders.Schizophrenia research. Cognition · 2023Article
- The self-assessment scale of cognitive complaints in Schizophrenia: validation of the Arabic version among a sample of lebanese patients.BMC psychiatry · 2023Article
- Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia.Annals of general psychiatry · 2023Article
- Cross-Cultural Adaptation and Validation of the Serbian Version of the Brief Assessment of Cognition in Schizophrenia Scale.International journal of environmental research and public health · 2023Article
- Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia.BMC psychiatry · 2023Article
- Exploring the relationship of cognitive function with and without COVID-19 recovered schizophrenic patients.Frontiers in public health · 2023Article
- Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia.Schizophrenia research. Cognition · 2021Article
- Subjective cognitive complaints and relations to objective cognitive performance among Lebanese patients with schizophrenia.BMC psychiatry · 2021Article
- General description of cognitive deficits in schizophrenia and assessment tools in Lebanon: A scoping review.Schizophrenia research. Cognition · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 6 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAssessment of cognitive disorders in schizophrenia is becoming a part of clinical and research practice by using batteries that differ widely in their content. The Brief Assessment of Cognition in Schizophrenia (BACS) was developed to cover the main cognitive deficits of schizophrenia. The objective of this study was to assess concurrent validity of the Arabic version of the BACS with a standard neurocognitive battery of tests in Lebanese patients with schizophrenia and healthy controls.
methodsA sample of 120 stable inpatients diagnosed with schizophrenia and 60 healthy controls received the Arabic version of the BACS in a first session, and a standard battery in a second session.
resultsMean duration of completion for the BACS was 31.2 ± 5.4 min in patients with schizophrenia. All tests demonstrated significant differences between controls and patients (p < .01). Principal components analysis demonstrated that a one-factor solution best fits our dataset (64.8% of the variance). High Cronbach alpha was found (.85). The BACS composite scores were significantly correlated with the standard battery composite scores in patients (r = .73, p < .001) and healthy controls (r = .78, p < .001). Also, correlation analysis between the BACS sub-scores and the standard battery sub-scores showed significant results (p < .05).
conclusionResults showed that the Arabic version of the BACS demonstrated high ability to discriminate patients with schizophrenia from healthy controls and it is a useful tool for assessing cognition in patients with schizophrenia and could be used in clinical practice in Lebanon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.